| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/04/2026 | ±2.4% | +3.0% | under-priced |
| 05/05/2026 | ±2.9% | +3.3% | under-priced |
| 02/24/2026 | ±3.2% | +3.5% | under-priced |
| 11/04/2025 | ±2.1% | +10.8% | under-priced |
| 08/05/2025 | ±2.5% | -7.4% | under-priced |
| 05/05/2025 | ±2.5% | +2.0% | over-priced |
| 02/25/2025 | ±2.0% | -2.3% | under-priced |
| 11/05/2024 | ±1.9% | -4.6% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.82 | $3.5B | $94M |
| Q1 FY2026 | $0.92 | $3.4B | $107M |
| Q4 FY2025 | — | $3.4B | $101M |
| Q3 FY2025 | $0.84 | $3.3B | $101M |
Henry Schein, Inc. Common Stock (HSIC) reports in 6 days, with the next report estimated for 11/03/2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 4.6% on average — the market has tended to under-price HSIC's earnings risk. Fundamentals into the print: EPS up 17.1% year-over-year, revenue up 6.7%. QuantLogix's live 5-factor engine currently reads HSIC as a buy at 68/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →